50 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Midatech Pharma, Inc. MTP stock moved upwards by 93.8% to $1.32 during Wednesday's pre-market session.
• InVivo Therapeutics Hldg, Inc. NVIV stock rose 31.0% to $0.38.
• Applied Therapeutics, Inc. APLT stock surged 25.0% to $32.69.
• Verastem Oncology, Inc. VSTM shares moved upwards by 15.1% to $1.45.
• vTv Therapeutics, Inc. VTVT stock moved upwards by 6.5% to $1.89.
• Bio-Path Holdings, Inc. BPTH stock rose 5.7% to $8.30. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $25.00.
• BioNTech, Inc. BNTX stock increased by 5.1% to $45.55. The most recent rating by Wolfe Research, on November 05, is at Outperform, with a price target of $21.00.
• Personalis, Inc. PSNL stock surged 5.0% to $11.45. The most recent rating by Morgan Stanley, on November 15, is at Overweight, with a price target of $16.00.
• CannTrust Holdings, Inc. CTST shares increased by 4.8% to $1.09.
• Xenetic Biosciences, Inc. XBIO stock increased by 4.8% to $1.54.
• AVEO Pharmaceuticals, Inc. AVEO shares rose 4.4% to $0.71.
• Kala Pharmaceuticals, Inc. KALA stock increased by 4.4% to $4.50. According to the most recent rating by Bank of America, on December 17, the current rating is at Neutral.
• Achieve Life Sciences, Inc. ACHV stock surged 4.0% to $0.58.
• Akorn, Inc. AKRX stock rose 4.0% to $1.30.
• Vascular Biogenics, Inc. VBLT stock rose 4.0% to $1.30.
• Solid Biosciences, Inc. SLDB shares moved upwards by 3.9% to $4.49. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
• KemPharm, Inc. KMPH shares moved upwards by 3.7% to $0.56. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
• TRACON Pharmaceuticals, Inc. TCON shares rose 3.7% to $2.54. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
• Guardion Health Sciences, Inc. GHSI stock increased by 3.6% to $0.37.
• Anavex Life Sciences, Inc. AVXL shares moved upwards by 3.5% to $3.00.
• SCYNEXIS, Inc. SCYX stock increased by 3.3% to $0.93.
• Kitov Pharma, Inc. KTOV shares rose 3.1% to $0.82.
• Microbot Medical, Inc. MBOT stock surged 2.7% to $11.87. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
• Novan, Inc. NOVN stock rose 2.7% to $0.77. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
• DBV Technologies, Inc. DBVT shares moved upwards by 2.5% to $11.44. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.

Losers

• Genetic Technologies, Inc. GENE stock declined 18.0% to $3.70 during Wednesday's pre-market session.
• NeuroMetrix, Inc. NURO shares declined 9.6% to $3.35.
• Genprex, Inc. GNPX shares decreased by 9.5% to $0.38.
• ContraFect, Inc. CFRX stock plummeted 9.0% to $0.78.
• Ocugen, Inc. OCGN stock fell 7.2% to $0.59. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 6.8% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Intra-Cellular Therapies, Inc. ITCI shares decreased by 6.8% to $28.90. The most recent rating by Canaccord Genuity, on December 24, is at Buy, with a price target of $65.00.
• Outlook Therapeutics, Inc. OTLK shares plummeted 6.5% to $0.82.
• Ritter Pharmaceuticals, Inc. RTTR shares decreased by 6.3% to $0.22.
• Walgreens Boots Alliance, Inc. WBA stock decreased by 5.8% to $55.85. The most recent rating by SunTrust Robinson Humphrey, on December 18, is at Hold, with a price target of $60.00.
• Aevi Genomic Medicine, Inc. GNMX shares fell 5.4% to $0.19.
• Acorda Therapeutics, Inc. ACOR stock plummeted 4.9% to $2.32. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
• Diffusion Pharmaceuticals, Inc. DFFN stock decreased by 4.9% to $0.48. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
• Correvio Pharma, Inc. CORV shares declined 4.9% to $0.39. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
• Catalyst Pharmaceuticals, Inc. CPRX stock plummeted 4.4% to $4.11.
• Aethlon Medical, Inc. AEMD stock decreased by 4.3% to $1.10.
• Tyme Technologies, Inc. TYME stock fell 4.0% to $1.68.
• Proteostasis Therapeutics, Inc. PTI stock decreased by 4.0% to $2.16.
• Conatus Pharmaceuticals, Inc. CNAT shares plummeted 3.9% to $0.41.
• Cassava Sciences, Inc. SAVA stock fell 3.5% to $7.43. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
• Acasti Pharma, Inc. ACST stock declined 3.0% to $2.26. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
• Cellect Biotechnology, Inc. APOP stock declined 2.9% to $3.97.
• NewLink Genetics, Inc. NLNK shares declined 2.8% to $2.06.
• Advaxis, Inc. ADXS stock plummeted 2.3% to $1.27.
• SeaSpine Holdings, Inc. SPNE shares fell 2.2% to $12.75. According to the most recent rating by Wells Fargo, on December 12, the current rating is at Underweight.